Hypertriglyceridemia: Therapy

General measures Adjustment of existing underlying diseases to optimal levels (see “Drug therapy“). Increase physical activity to 2.5-5 hours per week of moderate aerobic exercise or 1.25-2.5 hours per week of intense aerobic exercise. Aim for normal weight! Determination of BMI (body mass index, body mass index) or body composition by means of electrical impedance … Hypertriglyceridemia: Therapy

Lipoprotein(a) Elevation (Hyperlipoproteinemia): Medical History

Medical history (history of the patient) represents an important component in the diagnosis of hyperlipoproteinemia (lipoprotein (a)-elevation or -decrease (hyperlipoproteinemia). Family History Is there a frequent history of dyslipidemia in your family? Are there any hereditary diseases in your family? Social history Is there any evidence of psychosocial stress or strain due to your family … Lipoprotein(a) Elevation (Hyperlipoproteinemia): Medical History

Apolipoproteins

Apolipoproteins are the protein portion of lipoproteins that transports water-insoluble lipids in the blood. The following forms of apolipoproteins can be distinguished: Apolipoprotein A1 (apo A1; APOA1). Apolipoprotein A2 (apo A2; APOA2) Apolipoprotein B (apo B; APOB) Apolipoprotein B-100 (apo B-100; APOB-106) Apolipoprotein E (apo E; APOE) Apolipoprotein E isoforms Different lipoproteins are occupied by … Apolipoproteins

Hypertriglyceridemia: Or something else? Differential Diagnosis

Endocrine, nutritional, and metabolic diseases (E00-E90). Obesity (obesity). Acromegaly – increase in size of body end limbs due to increased presence of growth hormone after completion of growth. Cushing’s disease/Cushing’s syndrome – disease in which a tumor in the ACTH-producing cells of the pituitary gland produces too much ACTH, resulting in increased stimulation of the … Hypertriglyceridemia: Or something else? Differential Diagnosis

Hypertriglyceridemia: Complications

The following are the most important diseases or complications that may be contributed to by hypertriglyceridemia: Eyes and ocular appendages (H00-H59). Visual disturbances Endocrine, nutritional and metabolic diseases (E00-E90). Somatopause, premature – due todegradation of triglycerides to free fatty acids (FA) and glycerol → suppression of growth hormone secretion (synonyms: somatotropic hormone (STH), somatotropin) as … Hypertriglyceridemia: Complications

Hypertriglyceridemia: Medical History

Medical history (history of illness) represents an important component in the diagnosis of hyperlipoproteinemia (hypertriglyceridemia). Family History Is there a frequent occurrence of dyslipidemia in your family? Are there any hereditary diseases in your family? Social history Is there any evidence of psychosocial stress or strain due to your family situation? Current medical history/systemic history … Hypertriglyceridemia: Medical History

Hypertriglyceridemia: Examination

A comprehensive clinical examination is the basis for selecting further diagnostic steps: General physical examination – including blood pressure, pulse, body weight, height; further: Inspection (viewing). Skin, mucous membranes and sclerae (white part of the eye) [xanthomas – small yellowish-white skin lesions]. Auscultation (listening) of the heart [early atherosclerosis (arteriosclerosis, hardening of the arteries) → … Hypertriglyceridemia: Examination

Hypertriglyceridemia: Test and Diagnosis

1st order laboratory parameters – obligatory laboratory tests. Triglycerides Total cholesterol and LDL/HDL ratio LDL cholesterol HDL cholesterol Fasting glucose (fasting blood glucose), if necessary oral glucose tolerance test (oGTT). Renal parameters – urea, creatinine, if necessary cystatin C or creatinine clearance. Uric acid Laboratory parameters 2nd order – depending on the results of the … Hypertriglyceridemia: Test and Diagnosis

Hypertriglyceridemia: Drug Therapy

Therapeutic target Lowering triglycerides (TG) should reduce cardiovascular risk. Therapy recommendations Fibrates are first-line agents. Note: Fibrates may lower triglyceride levels but, in studies, there has been no clear evidence of efficacy in combination with statins. Alternatively, nicotinic acid, omega-3 fatty acids (EPA, DHA), statins + nicotinic acid can be used. Note: The American Heart … Hypertriglyceridemia: Drug Therapy

Hypertriglyceridemia: Micronutrient Therapy

Within the framework of micronutrient medicine (vital substances), the following vital substances (micronutrients) are used for prevention: Omega-3 fatty acid docosahexaenoic acid. Omega-3 fatty acid eicosapentaenoic acid Omega-6 fatty acid gamma-linolenic acid Omega-6 fatty acid linoleic acid Secondary plant compounds daidzein, genistein and glycitein In the context of micronutrient medicine (vital substances), the following vital … Hypertriglyceridemia: Micronutrient Therapy